584 related articles for article (PubMed ID: 28779965)
1. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
3. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
[TBL] [Abstract][Full Text] [Related]
4. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
[TBL] [Abstract][Full Text] [Related]
5. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary.
Chen SS; Lee L
Gynecol Oncol; 1983 Aug; 16(1):95-100. PubMed ID: 6884834
[TBL] [Abstract][Full Text] [Related]
6. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.
Wafa M; Braicu EI; Muallem MZ; Richter R; Taube E; Sehouli J; Grabowski JP
Anticancer Res; 2019 Oct; 39(10):5617-5621. PubMed ID: 31570458
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review.
Lago V; Minig L; Fotopoulou C
Int J Gynecol Cancer; 2016 Oct; 26(8):1407-14. PubMed ID: 27465900
[TBL] [Abstract][Full Text] [Related]
11. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma.
Tsumura N; Sakuragi N; Hareyama H; Satoh C; Oikawa M; Yamada H; Yamamoto R; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Int J Cancer; 1998 Oct; 79(5):526-30. PubMed ID: 9761124
[TBL] [Abstract][Full Text] [Related]
12. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic spread among women with primary peritoneal carcinoma.
Eltabbakh GH; Mount SL
J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
[TBL] [Abstract][Full Text] [Related]
14. Lymph node metastasis in stages I and II ovarian cancer: a review.
Kleppe M; Wang T; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
Gynecol Oncol; 2011 Dec; 123(3):610-4. PubMed ID: 21982047
[TBL] [Abstract][Full Text] [Related]
15. Frequency and distribution of lymph node metastases in epithelial ovarian cancer.
Haller H; Mamula O; Krasevic M; Rupcic S; Fischer AB; Eminovic S; Manestar M; Perovic D
Int J Gynecol Cancer; 2011 Feb; 21(2):245-50. PubMed ID: 21721192
[TBL] [Abstract][Full Text] [Related]
16. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
[TBL] [Abstract][Full Text] [Related]
17. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
19. The Risk of Para-Aortic Lymph Node Metastases in Apparent Early Stage Ovarian Cancer.
Bacalbasa N; Balescu I; Vilcu M; Dima S; Diaconu C; Iliescu L; Filipescu A; Dimitriu M; Brezean I
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32138225
[No Abstract] [Full Text] [Related]
20. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]